US equities |
MU $1,045.56 ▲+0.00% INTC $112.50 ▲+0.00% NVDA $239.24 ▲+0.00% AMD $649.42 ▲+0.00% SNDK $1,660.46 ▲+0.00% SPCX $171.92 ▲+0.00% MRVL $287.01 ▲+0.00% GOOG $344.59 ▲+0.00%
FinancialContent

Latest News about Spravato

Recent news which mentions Spravato

Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
Tickers JNJ NEWS
Tags ketamine depression Bill Martin Psychedeclis for TDR
From Benzinga
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Tickers ABBV AMGN CURLF JAZZ
Tags Ketamine TCNNF CURLF
From Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
Tickers JNJ
Tags Spravato JNJ Ketamine Treatment
From Benzinga
Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year
Tickers JNJ
Tags Cannabis News Market News
From Benzinga
Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion
Tickers DELCF NAD
Tags DELCF Matt Stang Spravato
From Benzinga